Hashtag
Men's Weekly

Emyria delighted to be accepted into prestigious US pain initiative

Melbourne, Victoria - News Direct - 30 November 2022 -

Caption


Emyria Ltd (ASX:EMD) Michael Winlo tells Proactive the company has been accepted into the US National Institute of Health's (NIH) Preclinical Screening Platform for Pain program.

The NIH's National Institute of Neurological Disorders and Stroke (NINDS) — also the leading funder of neurological research in the US — will run the study as part of a broader initiative to stem the opioid public health crisis.

The issuer is solely responsible for the content of this announcement.

Health & Wellness

Will Anyone Notice My Clear Aligners? Here’s the Honest Truth

Hashtag.net.au - avatar Hashtag.net.au

Image by freepikClear aligners have become hugely popular in Australia, promising discreet orthodontic treatment without the obvious look of metal braces. Yet, despite their growing popularity, a co...

How to Pick the Best Hair Loss Treatment for You

Hashtag.net.au - avatar Hashtag.net.au

Hair loss invades the lives of millions worldwide, wreaking havoc with self-esteem and self-image. With so many to choose from—whether it is topical treatment and medications or newer surgical metho...

Understanding Root Canal Treatment: What You Need to Know

Hashtag.net.au - avatar Hashtag.net.au

Image by pvproductions on Freepik When it comes to dental health, many people hear the term root canal treatment and immediately feel a bit uneasy. This procedure often gets a bad reputation, but und...